CAN PHYSICIAN EDUCATION LOWER THE COST OF PRESCRIPTION DRUGS - A PROSPECTIVE, CONTROLLED TRIAL

被引:59
作者
FRAZIER, LM [1 ]
BROWN, JT [1 ]
DIVINE, GW [1 ]
FLEMING, GR [1 ]
PHILIPS, NM [1 ]
SIEGAL, WC [1 ]
KHAYRALLAH, MA [1 ]
机构
[1] UNIV N CAROLINA, SCH EDUC, CHAPEL HILL, NC 27514 USA
关键词
D O I
10.7326/0003-4819-115-2-116
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: To determine whether an educational program featuring a drug cost manual can assist physicians in reducing their patients' out-of-pocket prescription drug expenses. Design: Prospective controlled trial. Setting: A general internal medicine-teaching clinic in a university hospital. Participants: Fifty-one medical interns. Intervention: Thirty-one interns received a manual of comparative drug prices annotated with prescribing advice, two feedback reports, and weekly cost-oriented prescribing reminders. A control group concurrently participated in a manual-based educational program on cholesterol management. Measurements: Copies of 3012 prescriptions written over 8 months were analyzed. Main Results: Intervention group physicians prescribed less expensive drugs within classes of drugs. The change in drug price score per prescription was -0.15 (95% Cl, - 0.27 to - 0.04; P = 0.01). A score of 3 was assigned to the most expensive, 2 was assigned to intermediate-priced, and 1 was assigned to the least expensive drug or drugs in the class. An increase of 0.74 months' (Cl, 0.49 to 0.98; P < 0.001) supply of medication was dispensed per prescription, reducing dispensing fees. The program was well accepted by the physicians. Conclusion: This relatively simple educational intervention can help physicians to reduce their patients' drug expenses and may serve as a model for incorporating cost information into the routine practice of medicine.
引用
收藏
页码:116 / 121
页数:6
相关论文
共 41 条
[21]   DO BETA-BLOCKERS ALTER LIPIDS AND WHAT ARE THE CONSEQUENCES [J].
HOLTZMAN, E ;
ROSENTHAL, T ;
GOLDBOURT, U ;
SEGAL, P .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1987, 10 :S86-S93
[22]  
Hypertension Detection Follow-up Program Cooperative Group, 1979, JAMA-J AM MED ASSOC, V242, P2562, DOI DOI 10.1001/JAMA.1979.03300230018021
[24]  
KLEIN LE, 1981, J MED EDUC, V56, P504
[25]  
Kreling D H, 1989, Health Care Financ Rev, V10, P67
[26]   THE ECONOMICS OF GENERIC PRESCRIBING - WINNERS AND LOSERS [J].
LASAGNA, L .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1986, 256 (18) :2566-2566
[27]   MODIFYING TEST-ORDERING BEHAVIOR IN THE OUTPATIENT MEDICAL CLINIC - A CONTROLLED TRIAL OF 2 EDUCATIONAL INTERVENTIONS [J].
MARTON, KI ;
TUL, V ;
SOX, HC .
ARCHIVES OF INTERNAL MEDICINE, 1985, 145 (05) :816-821
[28]   GENERIC DRUGS AND THE PRESCRIBING PHYSICIAN [J].
NIGHTINGALE, SL ;
MORRISON, JC .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1987, 258 (09) :1200-1204
[29]   THE 24-HOUR EFFECTS OF GLYBURIDE AND CHLORPROPAMIDE AFTER CHRONIC TREATMENT OF TYPE-II DIABETIC-PATIENTS [J].
PROSSER, PR ;
KOSOLA, JW ;
BOWERS, CY .
AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 1985, 289 (05) :179-185
[30]  
ROBERTS WC, 1987, AM J CARDIOL, V60, pE33